Ireland: Ireland As A Location For Your Intellectual Property Trading Company

Last Updated: 1 May 2015
Article by John Menton, Caroline Devlin, Fintan Clancy, Conor Hurley, Ailish Finnerty and Olivia Mullooly
Most Read Contributor in Ireland, October 2018

Ireland offers many advantages to companies seeking to establish a base in Ireland to exploit intellectual property.

There is a low corporation tax rate in Ireland and it has what is considered to be a business-friendly taxation regime. In certain circumstances a company carrying on a trade of exploiting intellectual property which it has acquired can achieve a very low effective tax rate. Ireland is a common law jurisdiction with an independent and efficient court system, a wide range of legal protections for the creators/ owners of Intellectual Property Rights and the possibility of obtaining generous state grant assistance with research and development projects.

Ireland's highly educated, English-speaking workforce provides a wealth of human capital. A long-standing member of the European Union, it has strong trading links both in Europe and with the rest of the world. It also boasts a unique relationship with the USA, which has resulted in significant rates of foreign direct investment and research and development over recent decades.

We have set out below a brief overview of some of the tax, legal and funding advantages that Ireland has to offer companies looking at locating in Ireland to exploit or develop intellectual property.

TAX ISSUES

THE RATE OF CORPORATION TAX

One of the primary advantages that Ireland has to offer is its low rate of corporate tax. The standard rate of corporation tax on trading profits in Ireland is 12.5%.

In order to avail of the 12.5% rate of corporation tax a company must derive income from a trade that is actively carried on in Ireland. It is generally essential therefore that the profit making apparatus of the trade is located in Ireland and that the activity is controlled in Ireland. It is generally feasible for a company established in Ireland to exploit intellectual property to avail of the 12.5% rate if the company has sufficient personnel located in Ireland with the appropriate expertise and skills required to be in a position to manage the relevant portfolio of intellectual property.

Whilst company capital gains are generally subject to corporation tax, the gains are re-worked to ensure that the tax is charged at an effective 33% rate. Ireland has a participation exemption which exempts disposals of shares in certain companies provided certain conditions are met.

TAX RELIEF FOR CAPITAL EXPENDITURE ON INTANGIBLE ASSETS

Capital allowances can be claimed on capital expenditure incurred by companies on the provision of certain "specified intangible assets". The definition of specified intangible assets is widely drafted and includes, inter alia, the acquisition of or the licence to use:

  • patents and registered designs;
  • trademarks, brands, brand names, domain names and services marks;
  • copyright or related rights;
  • know-how, generally related to manufacturing or processing, secret information concerning industrial, commercial or scientific experience whether protected or not;
  • goodwill to the extent that it is directly attributable to specified intangible assets;
  • computer software or a right to deal in or use such software;
  • applications for grant or registration of patents, trademarks, copyrights etc; and
  • certain other rights.

The tax write off is granted as a capital allowance and the write off is available in line with the depreciation or amortisation charge for accounting purposes.

Alternatively, a company can elect to take the write off against its taxable income over a 15 year period. A clawback of the capital allowances claimed arises if the intellectual property is sold within five years of its acquisition (or 10 years in respect of capital expenditure incurred before 13 February 2013).

The capital allowances that are available can only be offset against income generated from exploiting intangible assets or as a result of the sale of goods or services that derive the greater part of their value from the intangible assets (referred to as a "relevant trade"). Furthermore, the aggregate amount of allowances that can be claimed was previously capped at 80% of profits from the relevant trade in a given accounting period. This cap has been removed with effect from 1 January 2015 so the aggregate amount of allowance is now 100%.

This relief can reduce the effective rate of corporation tax on intellectual property related income and helps to provide a valuable incentive to companies looking at locating their intellectual property operations in Ireland.

RESEARCH & DEVELOPMENT EXPENDITURE

Ireland also offers significant incentives to companies looking at locating their research and development ("R&D") activities in Ireland. There are two major incentives granted to companies that incur expenditure on R&D within Ireland and within the EEA generally (subject to certain conditions and limitations).

A company that incurs expenditure on R&D may avail of a tax credit of 25% on all R&D expenditure incurred on or after 1 January 2015.

The R&D credit reduces a company's corporation tax liability for the current year. The tax credit is in addition to tax deduction available at 12.5% for qualifying expenditure. The combined effect of these provisions is that it is possible to obtain tax relief at an effective rate of up to 37.5% of expenditure on R&D. The tax credit is available for offset against the current year corporation tax liability of the company or to be paid as 'tax free' remuneration to certain 'key employees' and any unused credit can be carried forward indefinitely to future periods. Excess credits can also be carried back against corporation tax paid in the previous period. Alternatively, a company may, provided certain conditions are satisfied, claim to have any remaining excess credit paid to it by the Revenue. The maximum repayment which can be claimed is limited to the greater of:

  1. the corporation tax paid by the company for the preceding 10 accounting periods; or
  2. the payroll liabilities (i.e. PAYE, PRSI and levies) accounted for by the company in the accounting period in which the qualifying R&D expenditure was incurred.

The tax credit is available on a group basis in respect of group expenditure on R&D. Relief is also available for a company that has not carried on all of the R&D itself:

  • A company which incurs expenditure on R&D can claim credit for certain amounts paid to a university to carry out R&D activities on its behalf. Relief in this case will be restricted to so much of the payment to the university as does not exceed the greater of €100,000 or 5% of the expenditure incurred by the company itself on R&D activities; and
  • A company which incurs expenditure on R&D can claim credit for certain amounts paid to another unconnected person (a person other than a university) to carry out R&D activities on its behalf. Relief in this case will be restricted to so much of the payment to the other person as does not exceed the greater of €100,000 or 15% of the expenditure incurred by the company itself on R&D activities.

Irish tax legislation also allows for a tax credit for capital expenditure on buildings or structures used for the purpose of carrying on R&D activity. Expenditure in this context extends to spending on the construction or refurbishment of a building or structure to be used to facilitate R&D. The tax credit amounts to 25% of the cost of the construction or refurbishment and is available on a proportional basis if at least 35% of the building is used for R&D facilities. The full R&D credit of 25% may be claimed in the year in which the expenditure was incurred. A 10 year claw back exists where the building or structure is sold or ceases to be used by the company for the purposes of R&D or for the purposes of the same trade.

There are a number of other features of Irish tax legislation which may be of benefit to companies seeking to establish a base in Ireland to exploit intellectual property.

CREDIT RELIEF FOR FOREIGN ROYALTY INCOME

Unilateral credit relief in respect of foreign withholding taxes on royalty income from non-treaty countries is available to companies in respect of royalties which are taxable as trading income.

WITHHOLDING TAX ON PATENT ROYALTY PAYMENTS

Patent royalties are the only form of royalty payment potentially subject to Irish withholding tax. A company can make patent royalty payments to a foreign company free of withholding tax if the recipient is:

  • not resident in Ireland; and
  • resident for the purposes of tax in a relevant territory (another EU Member State or in a country which has entered into a double taxation agreement with Ireland) which imposes a tax that generally applies to royalties receivable in that territory from outside sources.

In addition, royalties paid in respect of foreign registered patents can be paid to recipients outside of a relevant territory if certain conditions are met and with the prior approval of Irish Revenue.

DIVIDEND WITHHOLDING TAX (DWT)

Dividends paid by Irish resident companies are subject to a 20% withholding tax. However, there are a number of exemptions to enable dividends to be paid free from DWT. For example, dividends paid to any of the following persons are exempt from DWT:

  • a company or person resident in an EU/ treaty country (other than Ireland) and not under the control of Irish residents;
  • a company that is not resident in an EU/treaty country but is controlled by a person(s) who is/are resident in an EU/treaty country (other than Ireland) and which person(s) is/are not under the control of a person(s) not resident in an EU/treaty country (other than Ireland); or
  • a listed company or a 75% subsidiary of a listed company.

In each case, in order to avail of the exemption a declaration must be filed with the dividend paying company before the dividend is paid.

As a result of these exemptions it is generally possible to extract profits from an Irish resident company by way of dividends free from Irish tax.

STAMP DUTY

Transfers of intellectual property are exempt from stamp duty in Ireland. This exemption makes it feasible to transfer intellectual property to an Irish resident company without incurring a documentary tax.

TRANSFER PRICING

Provisions for the application of international transfer pricing norms apply in Ireland which require that transactions between associated entities be entered into "at arm's length." The provisions largely implement the OECD Transfer Pricing Guidelines and are relevant to IP trading companies to the extent that they are licensing IP to group companies or connected persons.

The regime only applies to trading transactions and there is an exemption for small and medium sized enterprises, specifically companies with fewer than 250 employees and either turnover of less than ¤50 million or assets of less than ¤43 million.

CONTROLLED FOREIGN COMPANY ("CFC") AND THIN CAPITALISATION RULES

Unlike many jurisdictions Ireland does not have any CFC or thin capitalisation rules.

IRISH INTELLECTUAL PROPERTY PROTECTION LAWS

The distribution of products/services that depend upon Intellectual Property Rights for a significant proportion of product value (books, film/video, music, software for example) from an Irish distribution base is a business activity that will enjoy significant and practical protection from Irish law. Indeed, the provisions of the Irish Trade Marks Act 1996 and the Copyright and Related Rights Act 2000 can be said to be "State of the Art" legislation. Owners of Intellectual Property will find that Irish law is better than the laws found in many of our major European partners. Better both in the sense that Irish law is up to date and in the sense that because Irish law is also based on the common law tradition it will be more familiar to North American, British and Commonwealth Businesses. Irish law meets the requirements of leading international texts such as the Berne Convention, the TRIPS Agreement and the 1996 Geneva Copyright treaties, as well as all relevant IP E.U. Directives. Ireland is one of the world's largest exporters of computer software and appropriate protections have been enshrined in Irish law to protect Intellectual Property Rights. Copyright laws in Ireland are currently under review to identify and, to the extent permissible under EU copyright directives, remove any barriers to innovation.

THE IRISH COPYRIGHT LANDSCAPE

The Irish copyright laws are informal; there is no need to register that a copyright exists. Protection for original literary and artistic works normally vests in the author and copyrights are freely transferable through licence agreements and assignments.

Irish copyright law now gives protection to original databases and, combined with the 15 year protection against unauthorised copying of the contents, the creators of multimedia works enjoy greater protection under Irish law than under most other copyright regimes.

The publishers of works in electronic format enjoy copyright protection in the form of film, sound recording and cable programme copyrights and broadcast organisations enjoy copyright protection for all kinds of distribution (cable, satellite). Internet distribution of works is specifically protected in the form of the "making available" right. Performers of works - musicians, actors, singers - enjoy copyright protection through a balanced system that involves contractual arrangements between performers and film, recording, and broadcasting industries.

Irish right holders operate within a well established and sophisticated network of collecting societies that have international links with similar organisations worldwide.

IRELAND AND COPYRIGHT ENFORCEMENT

A right holder seeking to enforce copyright in Ireland enjoys the benefits of a very sympathetic enforcement regime. A few of these features are worth highlighting:

  • self-help powers of search and seizure;
  • presumptions in court proceedings that the work is original and that the plaintiff is the owner of copyright in the work "unless the contrary is proved";
  • the ability to protect whistleblowers by concealing the identity of a source;
  • admissibility of hearsay evidence in certain circumstances;
  • criminal penalties of up to five years imprisonment and/or a fine of up to ¤127,000;
  • extensive court powers of search, seizure, confiscation and destruction of pirated copies;
  • wide powers to order payment of damages based upon conversion principles as well as the power to award punitive damages; and
  • speedy injunctive reliefs, including injunctive relief against internet service providers.

PATENTS

Under the Irish Patents Act 1992 (the "1992 Act"), full and short-term patents can be sought by registering an application with the Irish Patents Office. Alternatively, a patent may also be registered with the European Patents Office (EPO), provided the applicant has elected Ireland as a designated jurisdiction. In addition to setting out the application procedure, the 1992 Act enunciates the statutory prohibition against direct/ indirect infringement of a patent and/or contributory infringements.

A full-term patent lasts for 20 years, while a short term patent has a duration of 10 years. In late 2012/early 2013, Ireland signed the necessary agreements to enable it to participate in the unitary patent system. This system is subject to a number of additional steps before it can come into effect. Once in effect (which is likely to be late 2016, early 2017), an applicant may apply to the EPO for a patent with unitary effect in the participating EU Member States and such a patent shall enjoy protection in Ireland.

In a development that will be of interest to pharmaceutical companies operating, or intending to invest in Ireland, the 'Bolar' exemption in Irish patent law was broadened in late 2014 through the Intellectual Property (Miscellaneous Provisions) Act 2014. This exempts certain acts done with a view to satisfying the application requirements for a marketing authorisation for a product prior to the expiration of a patent.

Among the amendments made to the scope of the exemption are the following:

  • The exemption now covers applications for any marketing authorisation or similar instrument (rather than the previous wording that limited it to marketing authorisations set out in the underlying Directives 2004/27/EC and 2004/28/EC (i.e applications for marketing authorisations for generics and biosimilars)). The exemption should now be broad enough to cover applications in respect of new active substances.
  • The exemption clarifies that it extends to applications for a marketing authorisation in any third country (including outside the EU) as well as in the State; and
  • The use of the terminology in the legislation relating to a marketing authorisation that is required under Irish or foreign law "in order to sell or supply or offer to sell or supply" should cover a range of regulatory requirements that might arise under the laws of Ireland or of a third country.

REGISTERED DESIGNS

While Irish design law meets international standards in all respects, it has been specifically tailored to encourage inward investment and innovation in manufacturing (specifically spare parts) by limiting protection for functional, 'must-fit' and 'must-match' designs.

TRADE MARKS

The area of Trade Marks is regulated in Ireland by the Trade Marks Act 1996. In addition to domestic legislation, Ireland is also a party to the Community Trade Mark System, which provides for the registration of EU wide trade marks.

RESEARCH, DEVELOPMENT AND INNOVATION (RD&I) SUPPORT PROGRAMME

The Irish Government offers a range of financial support/grants for R&D carried out in Ireland.

The two state agencies (IDA Ireland and Enterprise Ireland) offer a full range of programmes to assist companies with research and innovation activities including funding, support for in-house R&D, sourcing new technologies and partnerships with other companies and third level institutions. Enterprise Ireland supports companies through the provision of grants dependant on the specific nature of the R&D required. A Technical Feasibility Study Grant will assist a company in investigating the viability of manufacturing a new product or process or to develop a new internationally traded service and is available to companies with more than ten employees and that engage in an eligible service activity or manufacturing in Ireland. The grant funding available is restricted to 50% of eligible expenditures up to a maximum of ¤35,000.

R&D funding is also available in the form of Small Project Grants and Standard Project Grants for manufacturing or internationally traded services companies that can show adequate cash resources to implement the proposed project.

For large companies, the grant is restricted to 25% of the costs of the project, if the research is considered innovative and technically challenging and involving significant risk. This can be increased by 15% where there is collaboration between two companies, subject to a maximum grant of 50%. RD&I support is subject in all cases to an upper limit in respect of a particular industrial undertaking depending on the nature of the expenditure. Applications for support of up to ¤650,000 should be made to the R&D Fund Committee, and for amounts greater than that to the Investment Committee of Enterprise Ireland. While generally, the maximum R&D grant a company can receive is ¤650,000, projects in excess of this amount are evaluated on a case by case basis and higher grants are capable of being awarded.

OTHER RESEARCH SUPPORT PROGRAMMES

The IDA provides support for research, development and innovation operations, while the Enterprise Ireland Innovation Partnership Programme provides financial support to encourage companies to undertake collaborative projects with Irish third-level institutions.

See: http://www.idaireland.com/businessin-ireland/activities/research-development-and-innovation/ for further detail on IDA Ireland RD&I Grant assistance;

http://www.enterprise-ireland.com/en/Research-Innovation for further detail on Enterprise Ireland RD&I assistance; and

http://www.sfi.ie/funding/funding-calls/open-calls for further detail on grants available from Science Foundation Ireland.

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Mason Hayes & Curran
Dillon Eustace
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Mason Hayes & Curran
Dillon Eustace
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions